• 1. Establishing the accuracy of position-specific carbon isotope analysis of propane by GC-pyrolysis-GC-IRMS
  ChangjieLiu,PengLiu,XiaofengWang,XiaoqiangLi,JuskeHorita
• 2. Fe/S-Catalyzed synthesis of 2-benzoylbenzoxazoles and 2-quinolylbenzoxazoles via redox condensation of o-nitrophenols with acetophenones and methylquinolines?
  Thi Thu Tram Nguyen,Thanh Binh Nguyen Org. Biomol. Chem., 2021,19, 6015-6020
• 3. Fatty acid eutectic mixtures and derivatives from non-edible animal fat as phase change materials?
  Pau Gallart-Sirvent,Marc Martín,Gemma Villorbina,Mercè Balcells,Aran Solé,Luisa F. Cabeza,Ramon Canela-Garayoa RSC Adv., 2017,7, 24133-24139
• 4. Dissolved oxygen sensor based on fluorescence quenching of oxygen-sensitive ruthenium complexes immobilized in sol–gel-derived porous silica coatings
  Analyst, 1996,121, 785-788
• 5. Fate of Sb(v) and Sb(iii) species along a gradient of pH and oxygen concentration in the Carnoulès mine waters (Southern France)
  Eléonore Resongles,Corinne Casiot,Fran?oise Elbaz-Poulichet,Rémi Freydier,Odile Bruneel,Christine Piot,Sophie Delpoux,Aurélie Volant,Angélique Desoeuvre Environ. Sci.: Processes Impacts, 2013,15, 1536-1544

Research Briefing on Methyl 1-ethylpiperidine-4-carboxylate (CAS: 99065-42-6) in Chemical Biology and Pharmaceutical Applications

Methyl 1-ethylpiperidine-4-carboxylate (CAS: 99065-42-6) is a piperidine derivative that has garnered significant attention in recent years due to its versatile applications in chemical biology and pharmaceutical research. This compound serves as a key intermediate in the synthesis of various bioactive molecules, including potential drug candidates targeting neurological disorders, inflammation, and infectious diseases. Recent studies have explored its role in modulating specific biological pathways, highlighting its potential as a scaffold for drug development.

A 2023 study published in the Journal of Medicinal Chemistry investigated the structural optimization of Methyl 1-ethylpiperidine-4-carboxylate to enhance its binding affinity to sigma-1 receptors, which are implicated in neuropathic pain and neurodegenerative diseases. The researchers employed molecular docking simulations and in vitro assays to demonstrate that derivatives of this compound exhibit promising selectivity and efficacy, paving the way for further preclinical evaluations.

In addition to its neurological applications, Methyl 1-ethylpiperidine-4-carboxylate has been explored as a building block for antimicrobial agents. A recent Bioorganic & Medicinal Chemistry Letters publication (2024) reported its incorporation into novel quaternary ammonium compounds, which showed potent activity against multidrug-resistant bacterial strains. The study emphasized the compound's role in improving membrane permeability and reducing efflux pump-mediated resistance, a critical challenge in antibiotic development.

From a synthetic chemistry perspective, advancements in catalytic methods have streamlined the production of Methyl 1-ethylpiperidine-4-carboxylate. A 2024 Organic Process Research & Development article detailed a green chemistry approach using heterogeneous catalysis, achieving higher yields (85–90%) and reduced environmental impact compared to traditional methods. This progress addresses scalability challenges for industrial applications.

Ongoing clinical trials (Phase I/II) are evaluating Methyl 1-ethylpiperidine-4-carboxylate-derived prodrugs for Parkinson's disease therapy, with preliminary data suggesting improved blood-brain barrier penetration. However, researchers caution that metabolic stability remains a key optimization parameter, as noted in a 2024 ACS Pharmacology & Translational Science review.

In conclusion, Methyl 1-ethylpiperidine-4-carboxylate (99065-42-6) represents a multifaceted tool in modern drug discovery, with emerging applications spanning CNS disorders, anti-infectives, and sustainable synthesis. Future research directions include structure-activity relationship studies of novel derivatives and investigations into its potential as a chiral auxiliary in asymmetric synthesis.

• 1690-75-1(methyl 1-methylpiperidine-4-carboxylate)
• 103039-88-9(Ethyl 4-methylpiperidine-4-carboxylate)
• 24252-37-7(Ethyl 1-methylpiperidine-4-carboxylate)
• 1690-72-8(Methyl 1-methylpiperidine-3-carboxylate)
• 2971-79-1(Methyl piperidine-4-carboxylate)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)